Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hellmann

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Cancer Research|April 1, 1974
Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propaneA J Salsbury, K Burrage, K Hellmann
British Medical Journal|November 7, 1970
Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristicA J Salsbury, K Burrage, K Hellmann
European Journal of Cancer & Clinical Oncology|June 1, 1989
The pyrimido-pyrimidine derivatives RA233 and RX-RA85 affect cell cycle distribution of two murine tumour cell linesR B Lichtner, G Hutchinson, K Hellmann
Cancer Chemotherapy and Pharmacology|January 1, 1982
Razoxane penetration into the cerebrospinal fluid of ratsN Greig, F Xiao-Chang, K Hellmann
Cancer Chemotherapy Reports|December 1, 1971
Blood clearance of ICRF 159 (NSC-129943)E O Field, F Mauro, K Hellmann
Cancer Chemotherapy and Pharmacology|January 1, 1987
Reduction of vincristine toxicity by CronassialK Hellmann, G E Hutchinson, K Henry
Nature|May 9, 1970
Mode of action of the cytostatic agent "ICRF 159"H B Sharpe, E O Field, K Hellmann
Parasitology Research|August 21, 2003
The anthelmintic efficacy and the safety of a combination of imidacloprid and moxidectin spot-on in cats and dogs under field conditions in EuropeK Hellmann, T Knoppe, I Radeloff, et al.
Parasitology Research|October 18, 2005
Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field studyK Krieger, J Heine, P Dumont, et al.
British Journal of Cancer|August 1, 1974
Proceedings: Analysis of the antimetastatic action of the antimitotic agent ICRF 159K Hellmann, S E James, A J Salsbury
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Cancer Research|April 1, 1974
Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propaneA J Salsbury, K Burrage, K Hellmann
British Medical Journal|November 7, 1970
Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristicA J Salsbury, K Burrage, K Hellmann
European Journal of Cancer & Clinical Oncology|June 1, 1989
The pyrimido-pyrimidine derivatives RA233 and RX-RA85 affect cell cycle distribution of two murine tumour cell linesR B Lichtner, G Hutchinson, K Hellmann
Cancer Chemotherapy and Pharmacology|January 1, 1982
Razoxane penetration into the cerebrospinal fluid of ratsN Greig, F Xiao-Chang, K Hellmann
Cancer Chemotherapy Reports|December 1, 1971
Blood clearance of ICRF 159 (NSC-129943)E O Field, F Mauro, K Hellmann
Cancer Chemotherapy and Pharmacology|January 1, 1987
Reduction of vincristine toxicity by CronassialK Hellmann, G E Hutchinson, K Henry
Nature|May 9, 1970
Mode of action of the cytostatic agent "ICRF 159"H B Sharpe, E O Field, K Hellmann
Parasitology Research|August 21, 2003
The anthelmintic efficacy and the safety of a combination of imidacloprid and moxidectin spot-on in cats and dogs under field conditions in EuropeK Hellmann, T Knoppe, I Radeloff, et al.
Parasitology Research|October 18, 2005
Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field studyK Krieger, J Heine, P Dumont, et al.
British Journal of Cancer|August 1, 1974
Proceedings: Analysis of the antimetastatic action of the antimitotic agent ICRF 159K Hellmann, S E James, A J Salsbury
Pageof 12